Vimarsana
Biggest News Aggregation in the World

Page 39 - General Internal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from General Internal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In General Internal Today - Breaking & Trending Today

UPMC: Racial Disparities in Blood Thinner Use in VA Patients - Vimarsana News

UPMC: Racial Disparities in Blood Thinner Use in VA Patients

Black and Asian patients with atrial fibrillation are less likely to be treated with blood thinners than white patients, based on data from the U.S. Department of Veterans Affairs (VA). A paper published today in JAMA Network Open presents the findin

ACP and AHA Name Editor In Chief and Deputy Editor For Annals Of Internal Medicine: Clinical Cases - Vimarsana News

ACP and AHA Name Editor In Chief and Deputy Editor For Annals Of Internal Medicine: Clinical Cases

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
ACP and AHA Name Editor In Chief and Deputy Editor For Annals Of Internal Medicine: Clinical Cases - Vimarsana News

ACP and AHA Name Editor In Chief and Deputy Editor For Annals Of Internal Medicine: Clinical Cases

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
ACP and AHA Name Editor In Chief and Deputy Editor For Annals Of Internal Medicine: Clinical Cases - Vimarsana News

ACP and AHA Name Editor In Chief and Deputy Editor For Annals Of Internal Medicine: Clinical Cases

/PRNewswire/ -- The American College of Physicians (ACP) and the American Heart Association (AHA) announce the senior editorial leadership of the new digital,...

Most Direct-to-Consumer Drug Advertisements Do Not Adhere to FDA Guidelines - Vimarsana News

Most Direct-to-Consumer Drug Advertisements Do Not Adhere to FDA Guidelines

Few DTC drug advertisements fully adhere to FDA guidelines, overall quality of information provided is low and some market drugs off-label